Biogen Pharma

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.26
-0.01 (-3.7%)
BSENSE

Oct 09

BSE+NSE Vol: 91.79 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
GSB Finance
Qgo Finance
Easun Capital Ma
Anupam Finserv
Margo Finance
Stanrose Mafat.
Bridge Securitie
ISL Consulting
Yamini Invest
Biogen Pharma
Bervin Invest.
Why is Biogen Pharmachem Industries Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.22%
  • Poor long term growth as Operating profit has grown by an annual rate -6.10% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.07
2
Flat results in Jun 26
  • NO KEY NEGATIVE TRIGGERS
3
Stock is technically in a Bearish range
  • The technical trend has improved from Bearish on 01-Sep-26 and has generated -3.57% returns since then
  • The stocks MACD and KST technical factors are also Bearish
4
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -64.47%, its profits have fallen by -114.1%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biogen Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Biogen Pharma
-64.38%
-1.17
55.28%
Sensex
-11.8%
-0.48
13.44%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-11.48%
EBIT Growth (5y)
-6.10%
EBIT to Interest (avg)
1.07
Debt to EBITDA (avg)
2.60
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0.43%
ROE (avg)
2.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
22
Price to Book Value
0.28
EV to EBIT
5.72
EV to EBITDA
5.72
EV to Capital Employed
-0.09
EV to Sales
-3.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-0.17%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...